シセキ マサユキ   SHISEKI Masayuki
  志関 雅幸
   所属   医学部 医学科(東京女子医科大学病院)
   職種   准教授
論文種別 原著
言語種別 英語
査読の有無 査読あり
表題 Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy.
掲載誌名 正式名:International journal of clinical oncology
略  称:Int J Clin Oncol
ISSNコード:(1437-7772)1341-9625(Linking)
掲載区分国外
巻・号・頁 22(5),pp.972-979
著者・共著者 Shiseki Masayuki†*, Yoshida Chikashi, Takezako Naoki, Ohwada Akira, Kumagai Takashi, Nishiwaki Kaichi, Horikoshi Akira, Fukuda Tetsuya, Takano Hina, Kouzai Yasuji, Tanaka Junji, Morita Satoshi, Sakamoto Junichi, Sakamaki Hisashi, Inokuchi Koiti
担当区分 筆頭著者,責任著者
発行年月 2017/10
概要 Switching to dasatinib would be a therapeutic option for CP-CML patients who achieved MMR but not DMR by imatinib, especially for patients who wish to discontinue TKI therapy.
DOI 10.1007/s10147-017-1141-y
PMID 28550414